The AHA's 7 steps shown to reduce heart disease
12/23/2015
The 'Life's simple 7' steps to a healthy heart, issued by the American Heart Association, have been proven to reduce the risk of cardiovascular disease.
FDA: men who have sex with men can now donate blood
12/22/2015
After nearly 30 years of gay men not being able to donate blood, the FDA have revised their donor policy to include men who have sex with men.
Protein-protein interaction activates and fuels leukemia cell growth
12/22/2015
Building upon previous research, scientists at University of California, San Diego School of Medicine and UC San Diego Moores Cancer report that a protein called Wnt5a acts on a pair of...
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, has announced that it has initiated a Phase I/II study of its affinity enhanced...
Immune suppressor cells identified for advanced prostate cancer
12/22/2015
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD...
"Metal" drugs to fight cancer
12/22/2015
A new study improves our understanding of chemotherapy agentsWhat is the mechanism of action of metal-based chemotherapy drugs (the most widely used for treating common cancers like testicular or...
TSRI and St. Jude scientists study single 'transformer' proteins with role in cancer
12/22/2015
A new study led by scientists at The Scripps Research Institute (TSRI) and St. Jude Children's Research Hospital shows how a protein involved in cancer twists and morphs into different structures.
Immunotherapy could benefit patients with advanced non-small-cell lung cancer
12/22/2015
Results from a pivotal phase 2/3 trial show more patients with advanced non-small-cell lung cancer could benefit from the FDA-approved immunotherapy drug pembrolizumab.
New target for potential blood cancer treatment
12/22/2015
Mutations present in a blood cancer known as follicular lymphoma have revealed new molecular targets for potential treatments, according to researchers at Queen Mary University of London (QMUL)...
A first-of-its-kind (anti-PD-1) immunotherapy has been approved by the U.S. Food & Drug Administration as first-line treatment for metastatic melanoma, allowing greater access to this therapy for...